Arachidonic Acid Market is Expected to Reach US$ 422.7 Billion by 2032 | CAGR of 4.9% During 2024-2032

IMARC Group has recently released a new research study titled “Arachidonic Acid Market Report by Source (Animal, Plant), Form (Dry, Liquid), End User (Food and Beverage, Pharmaceuticals, and Others), and Region 2024-2032: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2024-2032”, offers a detailed analysis of the market drivers, segmentation, growth opportunities, trends, and competitive landscape to understand the current and future market scenarios.

The global arachidonic acid market size reached US$ 271.5 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 422.7 Billion by 2032, exhibiting a growth rate (CAGR) of 4.9% during 2024-2032.

Global Arachidonic Acid Market Trends:

With the increasing focus on advanced skincare formulations, as the cosmetic industry evolves, there is a rising demand for ingredients like arachidonic acid, known for its anti-inflammatory and skin-repairing properties, which enhances the effectiveness of high-end skincare and anti-aging products, strengthening the market growth. Moreover, with growing application in veterinary nutrition as the pet care industry advances, arachidonic acid is increasingly used in pet food and supplements to support joint health, inflammation management, and overall wellness in animals, providing an impetus to the market growth.

Factors Affecting the Growth of the Arachidonic Acid Industry:

Growing demand in the nutraceutical and dietary supplement industry: Arachidonic acid is increasingly recognized for its potential health benefits, particularly in the nutraceutical and dietary supplement markets. As consumers become more health-conscious, there is rising interest in supplements that support cardiovascular health, cognitive function, and overall well-being. Arachidonic acid, an omega-6 fatty acid, is believed to play a crucial role in inflammatory responses and muscle growth. This has led to a surge in its inclusion in dietary supplements and functional foods designed to promote health and prevent disease. The expanding awareness of the benefits of personalized nutrition and dietary supplements as it is incorporated into formulations aimed at improving athletic performance, supporting immune function, and enhancing general health is contributing to the market growth.

Increasing use in the pharmaceutical industry: Arachidonic acid and its derivatives are utilized in the development of various pharmaceutical products, including anti-inflammatory and pain relief medications. Its role as a precursor in the biosynthesis of eicosanoids, which are involved in inflammatory and immune responses, makes it valuable for drug development. Researchers and pharmaceutical companies are exploring the therapeutic potential of arachidonic acid in treating chronic inflammatory diseases, such as arthritis and cardiovascular conditions. Additionally, arachidonic acid is used in research to develop targeted therapies and novel treatments. This growing application in pharmaceuticals, driven by ongoing research and development activities, is bolstering the demand for arachidonic acid.

Rising awareness of its role in infant nutrition: The role of arachidonic acid in infant nutrition is also a key factor driving market growth. Arachidonic acid is an essential fatty acid critical for the development of the brain and visual system in infants. Its inclusion in infant formulas and nutritional supplements is supported by research highlighting its benefits for cognitive and visual development. As awareness of the importance of optimal infant nutrition increases, there is a growing demand for formula products enriched with arachidonic acid. This is particularly relevant in markets with high birth rates or where breastfeeding rates are lower, as infant formula becomes a primary source of nutrition. The emphasis on providing well-balanced, nutrient-rich formulas for infants is impelling the growth of the arachidonic acid market.

Key Companies:

• BASF SE
• Bio-Techne Corporation
• Cargill Incorporated
• Cayman Chemical Company
• Croda International Plc
• Kingdomway Nutrition Inc
• Koninklijke DSM N.V. and Merck KGaA

Arachidonic Acid Market Report Segmentation:

Key Market Segmentation:

Breakup by Source:

• Animal

• Plant

Breakup by Form:

• Dry

• Liquid

Based on the form, the market is segmented into dry and liquid.

Breakup by End User:

• Food and Beverage

• Pharmaceuticals

• Others

Based on end users, the market is classified into food and beverage, pharmaceuticals, and others.

Breakup by Region:

• North America

• Asia-Pacific

• Europe

• Latin America

• Middle East and Africa

Based on the region, the market is segregated into North America (the United States and Canada), Asia-Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others), Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others), Latin America (Brazil, Mexico, and others), and Middle East and Africa.

Key Highlights of the Report:

• Market Performance (2018-2023)

• Market Outlook (2024-2032)

• Market Trends

• Market Drivers and Success Factors

• Impact of COVID-19

• Value Chain Analysis

• Comprehensive mapping of the competitive landscape

If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.

About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact us:

IMARC Group

134 N 4th St. Brooklyn, NY 11249, USA

Email: [email protected]

Tel No:(D) +91 120 433 0800

United States: +1-631-791-1145